Nutrition and coronary heart disease

Comprehensive Therapy

Volumn 24, Issue 4, 1998, Pages 198-204

  Pandya, Dipak P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN; ASCORBIC ACID; CARBOHYDRATE; CAROTENOID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MINERAL; PROBUCOL; PROTEIN; SELENIUM; VITAMIN;

DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DRUG MECHANISM; EXERCISE; FRUIT; HUMAN; ISCHEMIC HEART DISEASE; NUTRITION; REVIEW; SMOKING CESSATION; VEGETABLE;

CORONARY DISEASE; DIET, FAT-RESTRICTED; DIETARY FIBER; HUMANS; NUTRITION PHYSIOLOGY; NUTRITIONAL REQUIREMENTS; PRIMARY PREVENTION;

EID: 0031979658     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Bidlack WR. Interrelationships of food nutrition, diet and health. The National Association of State Universities and Land Grant Colleges. White paper.[Review]. J Am College Nutrition. 1996;15(5):420-433.
2. Hoffmeister H, Mensink GB, Stolzenberg H, et al. Reduction of coronary heart diseases' risk factors in German cardiovascular study. Preventive Medicine. 1996;25(2):135-145.
3. Gutteridge JM. Anti-oxidants, nutritional supplements and life-threatening diseases [Review]. British J Biomedical Science. 1994;51(3):288-295.
4. McGehee NM, Johnson EQ, Rasmussen HM, Sahyoun N, Lynch MM, Carey M. Benefits and casts of medical nutrition therapy by registered.dietitian for patients with hypercholesterolemia, Massachusetts Dietetic Association. J Am Dietetic Association. 1995;95(9):1041-1043.
5. Scriber CR, Beudet AL, Sly WS, Fridrickson DS. The Metabolic and Molecular Bases of Inherited Disease. Volume II, 7th Edition. MacGraw Hill Co; 1995.
6. Eaton DL, Fless GM, Kohn WJ. Partial aminoacid sequences of the apolipoprotein(a) shows that it is homologous to plasminogen. Proceeding of National Academy Of Sci USA. 1987; 84:3224.
7. Guralcar A, Hoeg JM, Kostner G, et al. Levels of Lp(a) declines with niacin and neomycin treatment. Atherosclerosis. 1985;57:293.
8. Albert JJ, Taggart HM, Applebaum Bowder D. Reduction of lecithin-cholesterol acyltransference apolipoprotein D, and Lp(a) lipoprotein with the anabolic steroid stanozol. Biochem Biophys Acta. 1984;795:293.
9. Brody T. Nutritional Biochemistry, Biochem of Lipids in CVS Diseases. CA: Academic Press, Inc; 1994.
10. Maurice E, Olson J, Shike M. Modern Nutrition in Health and Disease. 8th Edition. 1994.
11. Myant NB. The Biology of Cholesterol and Related Sterols. London: W. Heinemann Medical Books, Ltd; 1981.
12. Lehtimaki T, Porkka K, Viikaraj J, Ehnholm C, Akerblom HK. Nikkari T. Apolipoprotein E phenotypes and serum lipids in new born and 3-year-old children: Cardiovascular risk in young Finn-study. 1994:94(4 pt 1):489-493.
13. Kritchevsky D, Moyer AW, Tesar WC, et al. Cholesterol vehicle in experimental atherosclerosis. II. Effect of unsaturation. Am J Physiology. 1956;185:279.
14. Oster G, Thompson D. Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart diseases in the United States. J Am Dietetic Association. 1996:96(2):127-131.
15. Howard GC, Pizzo SV. Biology of disease: Lipoprotein(a) and its role in atherothrombotic disease. Lab Investigation. 1993;69:373.
16. Berg K. A new serum type system in man - the Lp system. Acta Pathol. 1963;59:369.
17. Position paper on trans fatty acids. ASCN/AIN. Task force on trans-fatty acids. American Society For Clinical Nutrition and American Institute Of Nutrition [Review]. 1996; 63(5):663-670.
18. Heckers H, Korner M, Tusihen TWL, Melcher FW. Occurrence of individual trans isomeric fatty acids in human myocardium, jejunum and aorta in relation to different degrees of atherosclerosis. Atherosclerosis. 1977:28:389.
19. Stender S, Dyerberg J, Holmer G, Ovesen J, Saandstrom B. The influence of trans fatty acids on health: a report from the Danish nutrition council. Clinical Science. 1995;88(4): 375-392.
20. Thomas CB, Jones PR, Winter JA, Smith H. Hydrogenated oils and fats:the presence of chemically modified fatty acids in human adipose tissue. Am J Clin Nutr. 1981;34:877.
21. DeLorgeril M, Salen P, Martin JL, et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease: Insights into the cardioprotective effect of certain nutrients. J Am Coll Card. 1996;28(5):1103-1108.
22. Renaud S, de Lorgeril M. Nutrition, atherosclerosis and heart disease. Reproduction, Nutrition Development. 1994;34 (6):599-607.
23. Hrboticky N, Sellmayer A. Nutrition in prevention of coronary heart disease. Zeitschrift Fur Arztliche Fortbidung. 1996; 90(1):11-18.
24. Update: prevalence of overweight among children, adolescents and adults: United States, 1988-1994. MMWR. 1997; 46(9):198-202.
25. Daily dietary fat and total food-energy intake: third national health and nutrition examination survey, phase I, 1988-91. MMWR. 1994;43(7):1167,123-125.
26. Warshow H, Franz M, Pouros MA, Wheeler M. Fat replacers: their use in foods and role in diabetes medical nutrition therapy [Review]. Diabetes Care. 1996;19(11):1294-1301.
27. Gosselin P, Verreault R, Gaudreault C, Guillemette J. Dietary treatment of mild to moderate hypercholesterolemia: effectiveness of different interventions. Canadian Family Physician. 1996;42:2160-2167.
28. Grant WC, Fahrenbach MJ, Effect of dietary sucrose and glucose on plasma cholesterol in chicks and rabbits. Proc Soc Exp Biol Med. 1959;100:250.
29. Wells WW, Anderson SC. The increased severity of atherosclerosis in rabbits on a lactose-containing diet. J Nutr. 1959; 68:541.
30. Ahmed FE. Toxicological effects of ethanol on human health [Review]. Critical Reviews In Toxicology. 1995;25(4): 347-367.
31. Garg R, Wagener DK, Madans JH. Alcohol consumption and risk of ischemic heart disease in women. Archives of Internal Medicine. 1993;153(10):1211-1216.
32. Sirtori CR. Agradi E, Conti F, Mantero O, Gatti E. Soybean protein in the treatment of type II hyperlipoproteinamia. Lancet. 1977:1:275.
33. Sirtoi CR, Gatti E, Mantero O, et al. Clinical experience with soybean protein diet in the treatment of hypercholesterolemia. Am J Clin Nutr. 1979:32:1645.
34. Jackson AA, Langley Evans SC, McCarthy HD. Nutritional influences in early life upon obesity and body proportions [Review]. Ciba Foundation Symposium. 1996;201:118-129, 129-137,188-93.
35. Knauf VC, Facciotti D. Genetic engineering of foods to reduce the risk of heart disease and cancer [Review]. Advances in Experimental Medicine Biology. 1995;369:221-228.
36. Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med. 1975:292:1148.
37. Truswell AS, Beynen AC. Dietary fiber and plasma lipids: potential for prevention and treatment of hyperlipidaemias. In: Schweizer TF, Edwards CA, eds. Dietary Fiber: A Component of Food. London: Springer Verlag; 1992:295.
38. de Groot AP, Luyken R, Pikaar NA. Cholesterol lowering effect of rolled oats. Lancet. 1963;2:303.
39. Anderson JW, Spencer DB, Hamilton CC, et al. Oat bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr. 1990:52:495.
40. Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J. Hypercholesterolemic effects of oat bran or bean intake for hypercholesterolemic men. Am J Clin Nutr. 19S4;40: 1146.
41. Keys A, Grnde F, Anderson JT. Fiber and pectin in the diet and serum cholesterol concentrations in men. Proc Soc Exp Biol Med. 1961;106:555.
42. Ginter ES, Kubec FJ, Vozar J, Bobeck P. Natural hypercholesterolemic agent: pectin plus ascorbic acid. Int Journal Vitm Nutrn Res. 1979:49:406.
43. Cunnane SC, Ganguli S, Menard C, et al. High alpha-linoleic acid flaxeed (Linum usitatissimum): some nutritional properties in humans. British Journal Nutrn. 1993:69:443.
44. Owren PA, Hellem AJ, Odegaard A. Linoleic acid or the prevention of thrombosis and myocardial infarction. Lancet. 1964:2:975.
45. Reaven PD, Witztum JL, Parthasarathy S, Beltz WF. Effects of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotei against in vitro oxidation in human. Arteriosclerosis Thromo. 1992;12:318-324.
46. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxity induced by free radical peroxidation of lipids. J Lipid Research. 1983;24:1070-1076.
47. Devaraj S, Li D, Jialal I. The effects of α-tocopheral supplementation on monocyte function: decreased lipid oxidation, interleukin I β secretion, and monocyte adhesion to endothelium. J Clinical Investigation. 1996;98:756-763.
48. Traher MG, Sies H. Vitamin E in humans: demand and delivery [Review]. Annual Review of Nutrition. 1996;16:321-347.
49. Srain JJ. Putative role of dietary trace elements in coronary heart disease and cancer [Review]. British J Biomedical Science. Sept. 1994.
50. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzcr M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentration of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C [Review]. Am J Clin Nutr. 1993;57(5 suppl):7875-7975.
51. Morrison HI, Schaobel D, Desmeules M, Weigle DT. Serum folate and risk of fatal coronary heart disease. JAMA. 1996; 2275(24):1893-1896.
52. Swain RA, St Clair L. The role of folic acid in deficiency states and prevention of disease [Review]. J Family Practice. 1997;44(23):138-144.
53. Meddirr BS, Giles WH, Kittner SJ, Anda RF, Croff JB, Cooper ML. S. folate and risk for ischemic stroke: first National Health and Nutrition Examination Survey epidemiologic follow up study. Stroke. 1995;26(7):1766-1770.
54. Ubbink JB. Vitamin nutrition status and homocysteine and atherogenic risk factor [Review]. Nutritional Review. 1994; 52(11):383-387.
55. Lynch SR, Baynes RD. Deliberations and evaluations of the approaches end points and paradigms for iron dietary recommendations. J Nutrition. 1996;126(9 suppl):2404S-2409S.
56. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and risks of coronary artery disease. N Engl J Med. 1994;330(16):1119-1124.
57. Gillum RF, Sempos CT, Mackuc DM, Looker AC, Chien CY, Ingrom DD. S. transferrin saturation, stroke incidences and mortality in women and men: the NHANES I epideomiologic follow-up study: National Health and Nutrition Examination Survey. Am J Epidemiology. 1996,144(1):59-68.
58. Yamori Y, Nara Y, Mizushima S, Swamura M, Horie R. Nutritional factors for stroke and major cardiovascular diseases: international epidemiological comparison of dietary prevention. Health Reports. 1994;6(1):22-27.
59. Stahelin HB, Evison J, Seiler WO. Prevention of cerebrovascular insults [Review]. Schweizerische Medizinische Wochenschrift. J Swisse de Medecine. 1994;124(45):1995-2004.
60. Walker J, Ball M. Increasing calcium intake in women as a low fat diet. European J Clinical Nutrition. 1993;47(10):718-723.
61. Guidelines for school health programs to promote lifelong healthy eating [Review]. J School Health. 1997.
62. Blair SN, Horton E, Leon AS, et al. Physical activity, nutrition and chronic disease. Medicine & Science in Sports & Exercise. 1996;28(3):335-349.
63. Stein CE, Fall CH, Kumaran K, Osmond C, Barker DJ. Fetal growth and coronary heart disease in South India. Lancet. 1996;348(9037):1269-1273.
64. Martin CN, Barker DJ, Osmond C. Mothers' pelvic size, fetal growth and death from stroke and coronary heart disease in man in UK. Lancet. 1996;348(9037):1264-1268.
65. Gillum RF, Mussolino ME, Ingram DD. Physical activity and stroke incidence in women and men: the NHANES I epidemiologic follow-up study. Am J Epidemiology. 1996;143 (9):860-869.
66. Godfey KM, Barker DJ. Maternal nutrition in relation to fetal and placental growth [Review]. European J Obst Gyneco & Reproductive Biology. 1995;61(1):15-22.
67. Barker DJ. The Welcome Foundation Lecture, 1994. The fetal origins of adult disease. Proceeding of the Royal Society of London-Series B: Biological Sciences. 1995;262(1363):37-43.
68. Rocchini AP. Fetal and pediatric origins of adult cardiovascular disease. Current Opinion in Pediatrics. Oct. 1994; 6(5): 591-595.
69. Futrell N, Millikan GH. Strokes in emergency. Disease a Month. 1996;42(4):199-264.
70. Khasaev Ash, Shanavazova SA. Action of dietetic correction of nutrition on the effectiveness of rehabilitation of hospitalized patients with ischemic heart disease after myocardial infarct. Voprosy Pitaniia. 1995:(1):27-29.